Skip to main content
NewslettersWatchlist
hello world

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

Stocks in play: Eupraxia Pharmaceuticals Inc.

Baystreet.ca - Baystreet - Fri Aug 2, 8:48AM CDT

Today announced entry into a new $12-million convertible debt facility. Eupraxia Pharmaceuticals Inc. shares T.EPRX are trading unchanged at $3.83.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).